SVB Wealth LLC Has $2.71 Million Stake in Colgate-Palmolive (NYSE:CL)

SVB Wealth LLC reduced its holdings in Colgate-Palmolive (NYSE:CL) by 7.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 33,963 shares of the company’s stock after selling 2,804 shares during the period. SVB Wealth LLC’s holdings in Colgate-Palmolive were worth $2,707,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CL. OFI Invest Asset Management acquired a new position in shares of Colgate-Palmolive in the 3rd quarter valued at $25,000. Avion Wealth boosted its holdings in Colgate-Palmolive by 78.1% during the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after buying an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth about $34,000. Quarry LP increased its stake in shares of Colgate-Palmolive by 48.2% in the 2nd quarter. Quarry LP now owns 446 shares of the company’s stock valued at $34,000 after acquiring an additional 145 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC raised its position in shares of Colgate-Palmolive by 142.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after acquiring an additional 291 shares during the period. 80.41% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of brokerages recently issued reports on CL. Evercore ISI boosted their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. TheStreet raised Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, January 26th. Barclays lifted their target price on Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a report on Friday, April 12th. UBS Group raised their price target on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 29th. Finally, Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective for the company in a research report on Monday, January 29th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $89.50.

Insider Transactions at Colgate-Palmolive

In related news, Director C Martin Harris sold 2,760 shares of the firm’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the transaction, the director now directly owns 19,272 shares of the company’s stock, valued at $1,628,484. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, Director C Martin Harris sold 2,760 shares of the firm’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the sale, the director now directly owns 19,272 shares in the company, valued at approximately $1,628,484. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the transaction, the chief executive officer now directly owns 274,179 shares in the company, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. Insiders have sold a total of 232,371 shares of company stock worth $19,505,099 in the last 90 days. Corporate insiders own 0.37% of the company’s stock.

Colgate-Palmolive Price Performance

NYSE CL opened at $86.77 on Thursday. The firm’s 50 day moving average is $86.97 and its 200-day moving average is $80.63. The company has a quick ratio of 0.71, a current ratio of 1.11 and a debt-to-equity ratio of 8.59. The company has a market capitalization of $71.32 billion, a PE ratio of 31.21, a price-to-earnings-growth ratio of 3.28 and a beta of 0.42. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $90.37.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The firm had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.89 billion. During the same period in the previous year, the business earned $0.77 EPS. The company’s revenue was up 6.9% compared to the same quarter last year. Equities research analysts anticipate that Colgate-Palmolive will post 3.49 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. Colgate-Palmolive’s payout ratio is 69.06%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.